Soni Kiran Kumar, Shin Yu Seob, Choi Bo Ram, Karna Keshab Kumar, Kim Hye Kyung, Lee Sung Won, Kim Chul Young, Park Jong Kwan
Department of Urology, Chonbuk National University and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University, Jeonju.
College of Pharmacy, Kyungsung University, Busan.
Drug Des Devel Ther. 2017 Oct 11;11:2969-2979. doi: 10.2147/DDDT.S140543. eCollection 2017.
Finasteride is used to treat male pattern baldness and benign prostatic hyperplasia. This study investigated the toxicity of finasteride and recovery by DA-9401 using Sprague Dawley (SD) rats. Forty adult male SD rats were assigned to four groups: control (CTR), finasteride 1 mg/kg/day (F), finasteride 1 mg/kg + DA-9401 100 mg/kg/day (F + DA 100) and finasteride 1 mg/kg + DA-9401 200 mg/kg/day (F + DA 200). Treatments were by oral delivery once daily for 90 consecutive days. The gross anatomical parameters assessed included: genital organ weight; vas deferens sperm count and sperm motility; testosterone, dihydrotestosterone (DHT) and malondialdehyde levels; and histological and terminal deoxynucleotidyl transferase enzyme mediated dUTP nick-end labeling (TUNEL) staining of testis for spermatogenic cell density, Johnsen's score and apoptosis. Testicular tissue was also used for evaluating endoplasmic reticulum (ER) stress and apoptotic proteins. Epididymis weight, seminal vesicle weight, prostate weight, penile weight and vas deferens sperm motility showed significant differences between the F group and the CTR, F + DA 100 and F + DA 200 groups. There was no significant change in the testosterone level. DHT level decreased significantly in the F group compared with the CTR group. Testis tissue revealed significant changes in spermatogenic cell density, Johnsen's score and apoptotic index. Western blot showed significant changes in the ER stress and apoptotic markers. Finasteride resulted in reduced fertility and increased ER stress and apoptotic markers, which were recovered by administration of DA-9401 in the SD rats.
非那雄胺用于治疗男性型秃发和良性前列腺增生。本研究使用斯普拉格-道利(SD)大鼠,调查了非那雄胺的毒性以及DA-9401对其的恢复作用。将40只成年雄性SD大鼠分为四组:对照组(CTR)、非那雄胺1毫克/千克/天(F)、非那雄胺1毫克/千克 + DA-9401 100毫克/千克/天(F + DA 100)和非那雄胺1毫克/千克 + DA-9401 200毫克/千克/天(F + DA 200)。连续90天每天经口给药一次。评估的大体解剖学参数包括:生殖器官重量;输精管精子计数和精子活力;睾酮、二氢睾酮(DHT)和丙二醛水平;以及睾丸的组织学和末端脱氧核苷酸转移酶介导的dUTP缺口末端标记(TUNEL)染色,以评估生精细胞密度、约翰森评分和细胞凋亡。睾丸组织还用于评估内质网(ER)应激和凋亡蛋白。附睾重量、精囊重量、前列腺重量、阴茎重量和输精管精子活力在F组与CTR组、F + DA 100组和F + DA 200组之间存在显著差异。睾酮水平无显著变化。与CTR组相比,F组的DHT水平显著降低。睾丸组织显示生精细胞密度、约翰森评分和凋亡指数有显著变化。蛋白质印迹法显示ER应激和凋亡标志物有显著变化。非那雄胺导致生育力下降以及ER应激和凋亡标志物增加,而在SD大鼠中给予DA-9401可使其恢复。